Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models.
about
Guidance on the Selection of Appropriate Indicators for Quantification of Antimicrobial Usage in Humans and Animals.Forecasting ESKAPE infections through a time-varying auto-adaptive algorithm using laboratory-based surveillance data.European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach.Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units).Using informatics and the electronic medical record to describe antimicrobial use in the clinical management of diarrhea cases at 12 companion animal practices.Antimicrobial stewardship programs in health care systems.Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals.Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusOptimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistance. Insights from the society of infectious diseases pharmacists.Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.A proposed analytic framework for determining the impact of an antimicrobial resistance intervention.Time-series analysis of the relationship of antimicrobial use and hand hygiene promotion with the incidence of healthcare-associated infections.Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies.Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital.An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.Antifungal use influences Candida species distribution and susceptibility in the intensive care unit.Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study.ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animalsECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animalsDays of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption Metrics.
P2860
Q30245660-9574D235-AB56-42D4-AE83-3F06A8EA2F37Q30875040-E281780A-02DB-4A11-B5FD-2C59D9E4C6F1Q30960100-10E863C6-BA13-4D20-BC09-603883163143Q31032012-0FFBA4E8-C49A-46E2-8A72-88A1252AEFF7Q33946003-6871C31F-3F19-46B2-87B2-FCFEC1527044Q34097674-865FCA57-C8FE-4533-B5BE-9F7AC0BA19B9Q34099822-1F96A564-FCF7-4F42-88B2-D1D4E49F05FAQ34680578-B5378AE0-A1D3-40CE-AE54-703EC6A9316AQ35616181-E1221C02-5245-4926-BAF3-1B003DBEAB24Q35872823-8F6291B5-5A32-4732-9E6B-7965EE597859Q35873418-EA25595F-3B82-4D72-B973-E17B6655DAC4Q37731876-76253204-FE16-4ACC-AD51-7829326EA232Q38785263-799ABF7C-BD2D-45C3-8971-F2F3C3A48AEDQ39619903-BAC1A2BD-D4F7-4305-90A8-8899C1789092Q43590449-3A2DC10E-E485-4EF2-8149-B787D4F753BAQ44396652-073B6F02-4DF4-4C9D-BA78-EAFD37B8066CQ44756369-6C4CE95A-8BB0-4F76-8670-7E0E4A990E41Q45988034-DCE96570-1679-4A02-B643-E7E259D73D99Q46906475-75858E37-5925-40B0-8CDC-A5B7304AEA8BQ46943794-43A11B5A-E1C7-4904-B080-1B75C1D62BA6Q47156709-8B7A1C1C-76C2-40F1-A003-A8AED160E95EQ47159827-DC1082F8-9572-45D7-8894-8124D96481C9Q53100525-09ECA074-08A5-4206-B2D7-48963D428051
P2860
Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Making sense of antimicrobial ...... and transfer function models.
@ast
Making sense of antimicrobial ...... and transfer function models.
@en
type
label
Making sense of antimicrobial ...... and transfer function models.
@ast
Making sense of antimicrobial ...... and transfer function models.
@en
prefLabel
Making sense of antimicrobial ...... and transfer function models.
@ast
Making sense of antimicrobial ...... and transfer function models.
@en
P2093
P921
P1476
Making sense of antimicrobial ...... and transfer function models.
@en
P2093
Campillos P
López-Lozano JM
P356
10.1046/J.1469-0691.2001.00071.X
P478
P577
2001-01-01T00:00:00Z